Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 92

Sort by

Sort Order Select

Journal Articles

Development of Anti-CD3 Chimeric Antigen Receptor (CAR)-T Cells for Allogeneic Cell Therapy of Peripheral T-Cell Lymphoma (PTCL)

Hongliang Qian, Florence Pik Hoon Gay, Jane Wan Lu Pang, Yunqin Lee, Joshur Ang, Hwee Ching Tan, Erica SH Lek, Dario Campana, Ying Xim Tan

Blood (2022) 140 (Supplement 1): 4510–4511.

https://doi.org/10.1182/blood-2022-162222

Published: 2022

Journal Articles

Development of an Off-the-Shelf Chimeric Antigen Receptor (CAR)-T Cell Therapy for T-Cell Acute Lymphoblastic Leukemia (T-ALL) without Gene Editing

Xing Fah Alex Wong, Josie Ng, Simin Zheng, Rizal Ismail, Hongliang Qian, Dario Campana, Ying Xim Tan

Blood (2022) 140 (Supplement 1): 2358–2359.

https://doi.org/10.1182/blood-2022-165822

Published: 2022

Journal Articles

Clofarabine-Based Chemotherapy for KMT2A r Infantile Acute Lymphoblastic Leukemia

Tanja Andrea Gruber, Deqing Pei, John Kim Choi, Cheng Cheng, Elaine Coustan-Smith, Dario Campana, Hope Swanson, Jennifer L Pauley, Hiroto Inaba, Monika Metzger, Jeffrey E. Rubnitz, Raul C Ribeiro, Susana C. Raimondi, William E. Evans, Mary V. Relling, Ching-Hon Pui, Sima Jeha

Blood (2021) 138 (Supplement 1): 3406.

https://doi.org/10.1182/blood-2021-148936

Published: 2021

Journal Articles

Reduced–dose intensity therapy for pediatric lymphoblastic leukemia: long-term results of the Recife RELLA05 pilot study

Francisco Pedrosa, Elaine Coustan-Smith, Yinmei Zhou, Cheng Cheng, Arli Pedrosa, Mecneide Mendes Lins, Marcia Pedrosa, Norma Lucena-Silva, Alessandra Maria de Luna Ramos, Ester Vinhas, Gaston K. Rivera, Dario Campana, Raul C. Ribeiro

Blood (2020) 135 (17): 1458–1466.

https://doi.org/10.1182/blood.2019004215

Published: 2020

Includes: Supplemental data

Journal Articles

Specific stimulation of T lymphocytes with erythropoietin for adoptive immunotherapy

Natasha Vinanica, Arthur Yong, Desmond Wong, Yi Tian Png, See Voon Seow, Masaru Imamura, Dario Campana

Blood (2020) 135 (9): 668–679.

https://doi.org/10.1182/blood.2019001645

Published: 2020

Includes: Supplemental data

Journal Articles

Improved outcomes for myeloid leukemia of Down syndrome: a report from the Children’s Oncology Group AAML0431 trial

Jeffrey W. Taub, Jason N. Berman, Johann K. Hitzler, April D. Sorrell, Norman J. Lacayo, Kelley Mast, David Head, Susana Raimondi, Betsy Hirsch, Yubin Ge, Robert B. Gerbing, Yi-Cheng Wang, Todd A. Alonzo, Dario Campana, Elaine Coustan-Smith, Prasad Mathew, Alan S. Gamis

Blood (2017) 129 (25): 3304–3313.

https://doi.org/10.1182/blood-2017-01-764324

Published: 2017

Includes: Supplemental data

Journal Articles

Minimal residual disease–guided therapy in childhood acute lymphoblastic leukemia

Dario Campana, Ching-Hon Pui

Blood (2017) 129 (14): 1913–1918.

https://doi.org/10.1182/blood-2016-12-725804

Published: 2017

Journal Articles

A First-in-Human Study of Autologous T Lymphocytes with Antibody-Dependent Cell Cytotoxicity (ADCC) in Patients with B-Cell Non-Hodgkin Lymphoma (NHL)

Michelle Poon, Yeh Ching Linn, Noriko Shimasaki, Lip Kun Tan, Liang Piu Koh, Elaine Coustan-Smith, Dario Campana

Blood (2016) 128 (22): 3031.

https://doi.org/10.1182/blood.V128.22.3031.3031

Published: 2016

Journal Articles

Outcome of children with hypodiploid ALL treated with risk-directed therapy based on MRD levels

Blood (2015) 126 (26): 2896–2899.

https://doi.org/10.1182/blood-2015-09-671131

Published: 2015

Journal Articles

Autologous Activated and Expanded Natural Killer Cells Are Safe and Clinically Actives in Multiple Myeloma

Alejandra Leivas, PhDstudent, Antonio Pérez-Martínez, MD PhD, María Jesús Blanchard, MD, Estela Martín Clavero, MD, Dario Campana, MD PhD, Juan José Lahuerta, MDPhD, Joaquín Martínez-López, MD PhD

Blood (2015) 126 (23): 1856.

https://doi.org/10.1182/blood.V126.23.1856.1856

Published: 2015

Journal Articles

Body Mass Index Is Not Associated with Early Treatment Response or Clinical Outcome in Children with Acute Lymphoblastic Leukemia

Hesham Eissa, MD, Yinmei Zhou, MS, John C Panetta, PhD, Emily Browne, RN, MSN, CPNP, Sima Jeha, MD, Dario Campana, MD PhD, William E. Evans, PharmD, Ching-Hon Pui, MD, Mary V. Relling, PharmD, Hiroto Inaba, MD PhD

Blood (2015) 126 (23): 1299.

https://doi.org/10.1182/blood.V126.23.1299.1299

Published: 2015

Journal Articles

Improvement in Treatment Outcome and Identification of a New Prognostic Parameter in Down Syndrome Acute Myeloid Leukemia (DS-AML): Results of the Children’s Oncology Group (COG) Phase III AAML0431 Trial

Jeffrey W Taub, MD, Jason N Berman, MD, Johann K. Hitzler, MD, April D. Sorrell, MD, Norman J. Lacayo, MD, Kelley Mast, MD, David R. Head, MD, Susana C. Raimondi, PhD, Betsy A. Hirsch, PhD, Robert B. Gerbing, MA, Todd A. Alonzo, PhD, Dario Campana, MD PhD, Elaine Coustan-Smith, MS, Prasad Mathew, Alan S. Gamis, MD MPH

Blood (2014) 124 (21): 278.

https://doi.org/10.1182/blood.V124.21.278.278

Published: 2014

Journal Articles

Autologous Activated and Expanded Natural Killer Cells Kill Clonogenic Myeloma Cells: A New Therapeutic Option for Multiple Myeloma

Alejandra Leivas, Graduate Student, Ruth M Risueño, PhD, Antonio Pérez-Martínez, MD PhD, María Jesús Blanchard, MD, Dario Campana, MD PhD, Juan José Lahuerta, MD PhD, Joaquín Martínez-López, MD PhD

Blood (2014) 124 (21): 3467.

https://doi.org/10.1182/blood.V124.21.3467.3467

Published: 2014

Journal Articles

Autonomous growth and increased cytotoxicity of natural killer cells expressing membrane-bound interleukin-15

Masaru Imamura, David Shook, Takahiro Kamiya, Noriko Shimasaki, Sally M. H. Chai, Elaine Coustan-Smith, Chihaya Imai, Dario Campana

Blood (2014) 124 (7): 1081–1088.

https://doi.org/10.1182/blood-2014-02-556837

Published: 2014

Includes: Supplemental data

Journal Articles

Prognostic Factors For Children With Acute Myeloid Leukemia Who Achieve Minimal Residual Disease-Negative Status After Induction Therapy

Seth E Karol, MD, Elaine Coustan-Smith, MS, Xueyuan Cao, PhD, Sheila A Shurtleff, PhD, Susana C Raimondi, PhD, John K Choi, MD, PhD, Raul C Ribeiro, MD, Gary V Dahl, MD, W Paul Bowman, MD, Jeffrey W Taub, MD, Barbara Degar, MD, Wing Leung, MD, PhD, James R Downing, MD, Ching-Hon Pui, MD, Jeffrey E Rubnitz, MD, PhD, Dario Campana, MD, PhD, Hiroto Inaba, MD, PhD

Blood (2013) 122 (21): 490.

https://doi.org/10.1182/blood.V122.21.490.490

Published: 2013

Journal Articles

Comprehensive genetic analysis of cytarabine sensitivity in a cell-based model identifies polymorphisms associated with outcome in AML patients

Blood (2013) 121 (21): 4366–4376.

https://doi.org/10.1182/blood-2012-10-464149

Published: 2013

Includes: Supplemental data

Journal Articles

Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt–β-catenin signaling

Bin Zhang, Min Li, Tinisha McDonald, Tessa L. Holyoake, Randall T. Moon, Dario Campana, Leonard Shultz, Ravi Bhatia

Blood (2013) 121 (10): 1824–1838.

https://doi.org/10.1182/blood-2012-02-412890

Published: 2013

Includes: Supplemental data

Journal Articles

Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia

Malek Faham, Jianbiao Zheng, Martin Moorhead, Victoria E. H. Carlton, Patricia Stow, Elaine Coustan-Smith, Ching-Hon Pui, Dario Campana

Blood (2012) 120 (26): 5173–5180.

https://doi.org/10.1182/blood-2012-07-444042

Published: 2012

Includes: Supplemental data

Journal Articles

Cytarabine-Induced Gene Expression Signatures in AML Patients and Its Association with Clinical Outcome.

Jatinder K. Lamba, PhD, Stanley Pounds, PhD, Xueyuan Cao, PhD, Kristine Crews, PharmD, Dario Campana, MD., PhD, James R. Downing, MD, Raul Ribeiro, MD, Jeffrey Rubnitz, MD, PhD

Blood (2012) 120 (21): 2470.

https://doi.org/10.1182/blood.V120.21.2470.2470

Published: 2012

Journal Articles

Deep Sequencing Approach for Minimal Residual Disease Detection in Acute Lymphoblastic Leukemia

Malek Faham, MD, PhD, Jianbiao Zheng, PhD, Martin Moorhead, PhD, Victoria Carlton, Patricia Lee Stow, BA, MS, Elaine Coustan-Smith, MS, Ching-Hon Pui, MD, Dario Campana, MD, PhD

Blood (2012) 120 (21): 1388.

https://doi.org/10.1182/blood.V120.21.1388.1388

Published: 2012

NARROW

Development of Anti-CD3 Chimeric Antigen Receptor (CAR)-T Cells for Allogeneic Cell Therapy of Peripheral T-Cell Lymphoma (PTCL)

Development of an Off-the-Shelf Chimeric Antigen Receptor (CAR)-T Cell Therapy for T-Cell Acute Lymphoblastic Leukemia (T-ALL) without Gene Editing

Clofarabine-Based Chemotherapy for KMT2A r Infantile Acute Lymphoblastic Leukemia

Reduced–dose intensity therapy for pediatric lymphoblastic leukemia: long-term results of the Recife RELLA05 pilot study

Specific stimulation of T lymphocytes with erythropoietin for adoptive immunotherapy

Improved outcomes for myeloid leukemia of Down syndrome: a report from the Children’s Oncology Group AAML0431 trial

Minimal residual disease–guided therapy in childhood acute lymphoblastic leukemia

A First-in-Human Study of Autologous T Lymphocytes with Antibody-Dependent Cell Cytotoxicity (ADCC) in Patients with B-Cell Non-Hodgkin Lymphoma (NHL)

Outcome of children with hypodiploid ALL treated with risk-directed therapy based on MRD levels

Autologous Activated and Expanded Natural Killer Cells Are Safe and Clinically Actives in Multiple Myeloma

Body Mass Index Is Not Associated with Early Treatment Response or Clinical Outcome in Children with Acute Lymphoblastic Leukemia

Improvement in Treatment Outcome and Identification of a New Prognostic Parameter in Down Syndrome Acute Myeloid Leukemia (DS-AML): Results of the Children’s Oncology Group (COG) Phase III AAML0431 Trial

Autologous Activated and Expanded Natural Killer Cells Kill Clonogenic Myeloma Cells: A New Therapeutic Option for Multiple Myeloma

Autonomous growth and increased cytotoxicity of natural killer cells expressing membrane-bound interleukin-15

Prognostic Factors For Children With Acute Myeloid Leukemia Who Achieve Minimal Residual Disease-Negative Status After Induction Therapy

Comprehensive genetic analysis of cytarabine sensitivity in a cell-based model identifies polymorphisms associated with outcome in AML patients

Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt–β-catenin signaling

Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia

Cytarabine-Induced Gene Expression Signatures in AML Patients and Its Association with Clinical Outcome.

Deep Sequencing Approach for Minimal Residual Disease Detection in Acute Lymphoblastic Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only